Surgical revascularization for stable coronary syndrome: the ISCHEMIA trial versus a single-centre matched population-a real-world analysis of patients undergoing surgical revascularization.
Andrea De MartinoFederico Del ReDario GregoriDanila AzzolinaClemente PascarellaGiosuè FalcettaGiacomo RavenniMichele CelientoRiccardo MorgantiAndrea ColliPublished in: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery (2022)
Long-term results in surgical patients treated for chronic coronary syndromes showed that ISCHEMIA trial findings are not transferable in a 'real-world' scenario and have not changed previous medical practice. A patient-tailored approach, especially with diabetes and reduced left ventricle function, offers the best results in patients with stable coronary artery disease.
Keyphrases
- coronary artery disease
- percutaneous coronary intervention
- coronary artery bypass grafting
- patients undergoing
- study protocol
- phase iii
- coronary artery
- healthcare
- cardiovascular events
- case report
- phase ii
- clinical trial
- type diabetes
- primary care
- cardiovascular disease
- pulmonary artery
- aortic stenosis
- mitral valve
- randomized controlled trial
- glycemic control
- smoking cessation
- metabolic syndrome
- quality improvement
- acute coronary syndrome
- left ventricular
- weight loss
- skeletal muscle
- newly diagnosed